Unlicensed and off-label prescription of systemic anti-infective agents to children

Paediatric and Perinatal Drug Therapy

Volumn 5, Issue 2, 2002, Pages 68-74

  'T Jong, Geert W ^a   Eland, Ingo A ^b   De Hoog, Matthijs ^a   Sturkenboom, Miriam C J M ^b   Van den Anker, John N ^a,c   Stricker, Bruno H Ch ^b  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Anti infective agents; Children; Epidemiology; Off label; Unlicensed

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIBODY; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIMYCOBACTERIAL AGENT; ANTIVIRUS AGENT; AZITHROMYCIN; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; COTRIMOXAZOLE; ENZYME INHIBITOR; ERYTHROMYCIN; HYDRAZIDE DERIVATIVE; IMMUNOGLOBULIN; MACROLIDE; PENICILLIN DERIVATIVE; PHENETICILLIN; ROXITROMYCIN; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM DERIVATIVE; UNCLASSIFIED DRUG; VACCINE;

ARTICLE; CHILD; CHILDHOOD; COHORT ANALYSIS; CONTROLLED STUDY; DRUG CLASSIFICATION; DRUG LABELING; DRUG USE; FEMALE; GENERAL PRACTITIONER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METHODOLOGY; PRESCRIPTION; RISK FACTOR;

EID: 0036447040     PISSN: 14630095     EISSN: None     Source Type: Journal    
DOI: 10.1185/146300902322125929     Document Type: Article

References (26)

1. Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed 1999;80:F142-144.
2. Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in paediatric wards: Prospective study. BMJ 1998;316:343-345.
3. Turner S, Nunn A, Choonara I. Unlicensed drug use in children in the UK. Paediatric and Perinatal Drug Therapy 1997;1:52-55.
4. Turner S, Gill A, Nunn T, Hewitt B, Choonara I. Use of "off-label" and unlicensed drugs in paediatric intensive care unit [letter]. Lancet 1996;347: 549-550.
5. Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ 2000;320: 79-82.
6. t Jong GW, Vulto AG, de Hoog M, Schimmel KJ, Tibboel D, van den Anker JN. Survey of the use of off-label and unlicensed drugs in a Dutch children's hospital. Pediatrics 2001;108:1089-1093.
7. Chalumeau M, Treluyer JM, Salanave B, et al. Off label and unlicensed drug use among french office based paediatricians. Arch Dis Child 2000;83: 502-505.
8. Olubadewo JO, Ikponmwamba A. Profile of prescription medication in a pediatric population. Drug Intell Clin Pharm 1988;22:999-1002.
9. Sanz EJ, Bergman U, Dahlstrom M. Paediatric drug prescribing. A comparison of Tenerife (Canary Islands, Spain) and Sweden. Eur J Clin Pharmacol 1989;37:65-68.
10. Thrane N, Sorensen HT. A one-year population-based study of drug prescriptions for Danish children. Acta Paediatr 1999;88:1131-1136.
11. Straand J, Rokstad K, Heggedal U. Drug prescribing for children in general practice. A report from the More & Romsdal Prescription Study. Acta Paediatr 1998;87:218-224.
12. Madsen H, Andersen M, Hallas J. Drug prescribing among Danish children: A population-based study. Eur J Clin Pharmacol 2001;57:159-165.
13. t Jong GW, Eland IA, Stricker BHC, Anker JNvd. Information for paediatric use of medicines in a product information compendium. Paediatric and Perinatal Drug Therapy 2001;4:1-4.
14. Klinkman MS, Green LA. Using ICPC in a computer-based primary care information system. Fam Med 1995;27:449-456.
15. Miller GC, Britt H. A new drug classification for computer systems: The ATC extension code. Int J Biomed Comput 1995;40:121-124.
16. Vlug AE, van der Lei J, Mosseveld BM, van Wijk MA, van der Linden PD, Sturkenboom MC, et al. Postmarketing surveillance based on electronic patient records: The IPCI project. Methods Inf Med 1999;38:339-344.
17. t Jong GW, Eland IA, Sturkenboom MCJM, Van Den Anker JN, Stricker BHC. Unlicensed and off-label prescription of drugs to children; population-based cohort study. BMJ 2002;324:1313-1314.
18. Guidance for Industry; Content and Format for Pediatric Use Supplements. Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Washington, 1996:1-6.
19. Nahata MC. New regulations for pediatric labeling of prescription drugs. Ann Pharmacother 1996;30:1032-1033.
20. Physician's Desk Reference. 56th Ed. Montvale, NJ: Medical Economics, 2001.
21. The Royal College of Paediatrics and Child Health: Medicines for Children. Hants, United Kingdom: B&MBC Books Ltd, Direct Books, 1999.
22. European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit; Committee for Proprietary Medicinal Products. Note for Guidance on Clinical Investigation of Medicinal Products in Children. 1997.
23. Christensen ML, Helms RA, Chesney RW. Is pediatric labeling really necessary? Pediatrics 1999;104:593-597.
24. van den Anker JN. Pharmacokinetics and renal function in preterm infants. Acta Paediatr 1996;85:1393-1399.
25. de Hoog M, Schoemaker RC, Mouton JW, van den Anker JN. Vancomycin population pharmacokinetics in neonates. Clin Pharmacol Ther 2000;67:360-367.
26. Wilson JT. An update on the therapeutic orphan. Pediatrics 1999;104:585-590.